Literature DB >> 2164529

Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis.

L Chiovato1, P Vitti, F Santini, G Lopez, C Mammoli, P Bassi, L Giusti, M Tonacchera, G Fenzi, A Pinchera.   

Abstract

Autoantibodies blocking the TSH-dependent production of cAMP in thyroid cells (TSH-BAb) have been described in atrophic thyroiditis (AT; idiopathic myxedema) and in neonates with transient hypothyroidism, but their incidence in autoimmune thyroiditis in relation to thyroid status remains to be completely established. To this purpose TSH-BAb were evaluated in a group of 140 consecutive patients with autoimmune thyroiditis, which included 26 cases of AT and 114 subjects with goitrous Hashimoto's thyroiditis (HT); among the goitrous group 27 were euthyroid (HT-E), 32 had subclinical hypothyroidism (HT-SH), and 55 had clinical hypothyroidism (HT-H). TSH-BAb were measured in immunoglobulin G prepared by DEAE-Sephadex A-50 by determining their ability to inhibit TSH-dependent cAMP production in a differentiated strain of cultured rat thyroid cells (FRTL-5). Using this sensitive and reproducible method, TSH-BAb were detected in 12 of 26 (46%) patients with AT, in 1 of 27 (3.7%) subjects with HT-E, in 3 of 32 (9.4%) with HT-SH, and in 20 of 55 (36%) with HT-H. The prevalence of TSH-BAb was higher in AT vs. HT-H (P less than 0.001), HT-SH (P less than 0.001), or HT-E (P less than 0.001), and in HT-H vs. HT-SH (P less than 0.001) or HT-E (P less than 0.001). Mean TSH-BAb levels in AT were higher than those in HT-H (P less than 0.005) and HT-SH (P less than 0.025); the difference was not significant between HT-H and HT-SH. An inverse correlation was found between TSH-BAb levels and estimated goiter weight (P less than 0.005). The results of the present study indicate that 1) in autoimmune thyroiditis TSH-BAb are detectable almost exclusively in hypothyroid patients, their prevalence being higher in overt hypothyroidism than in subclinical thyroid failure; 2) the prevalence of TSH-BAb and their mean levels are higher in hypothyroid patients with AT than in those with HT; and 3) therefore, the presence of circulating TSH-BAb appears to be related to the development of hypothyroidism and thyroid atrophy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164529     DOI: 10.1210/jcem-71-1-40

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.

Authors:  S Seo; M Sánchez Robledo
Journal:  J Endocrinol Invest       Date:  2018-09-07       Impact factor: 4.256

2.  Nongoitrous autoimmune thyroiditis with facial palsy.

Authors:  Hyung Jik Lee; Jin Kyung Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-12-31

3.  Hypothyroid Hashimoto's thyroiditis with scintigraphic and echo-color Doppler features mimicking autonomous adenoma.

Authors:  F Boi; M Piga; M Loy; S Mariotti
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

4.  Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis.

Authors:  Eva-Maria Siegmann; Helge H O Müller; Caroline Luecke; Alexandra Philipsen; Johannes Kornhuber; Teja Wolfgang Grömer
Journal:  JAMA Psychiatry       Date:  2018-06-01       Impact factor: 21.596

5.  Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT).

Authors:  R Elisei; A Pinchera; L Chiovato; C Mammoli; P Agretti; C Romei; F Santini; G Bendinelli; E Fiore; A Capaccioli; P Vitti
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

6.  Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.

Authors:  T Diana; J Krause; P D Olivo; J König; M Kanitz; B Decallonne; G J Kahaly
Journal:  Clin Exp Immunol       Date:  2017-05-16       Impact factor: 4.330

7.  Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

Authors:  L Chiovato; P Vitti; G Bendinelli; F Santini; E Fiore; A Capaccioli; M Tonacchera; C Mammoli; M Ludgate; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

8.  A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity.

Authors:  Y Li; J Kim; T Diana; R Klasen; P D Olivo; G J Kahaly
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

9.  Investigation of TSH receptor blocking antibodies in childhood-onset atrophic autoimmune thyroiditis.

Authors:  Keisuke Nagasaki; Akie Nakamura; Takeru Yamauchi; Hotaka Kamasaki; Yosuke Hara; Junko Kanno; Satomi Koyama; Yoshiaki Ohtsu; Ikuko Takahashi; Shigeru Suzuki; Kenichi Kashimada; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2021-04-03

Review 10.  Thyrotropin Receptor Blocking Antibodies.

Authors:  Tanja Diana; Paul D Olivo; George J Kahaly
Journal:  Horm Metab Res       Date:  2018-10-04       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.